Scholars@Duke

Mortality rates in comparative trials of formulations of amphotericin B.

Publication ,  Journal Article
Frothingham, R
Published in: Clin Infect Dis
August 15, 2001
Published version (DOI) Link to item

Duke Scholars

Richard Frothingham
Author Richard Frothingham Medicine, Infectious Diseases

Published In

Clin Infect Dis

DOI

10.1086/321906

ISSN

1058-4838

Publication Date

August 15, 2001

Volume

33

Issue

4

Start / End Page

582 / 583

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Randomized Controlled Trials as Topic
  • Phosphatidylglycerols
  • Phosphatidylcholines
  • Neutropenia
  • Mycoses
  • Microbiology
  • Liposomes
  • Humans
  • Fever
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Frothingham, R. (2001). Mortality rates in comparative trials of formulations of amphotericin B. Clin Infect Dis, 33(4), 582–583. https://doi.org/10.1086/321906
Frothingham, R. “Mortality rates in comparative trials of formulations of amphotericin B.” Clin Infect Dis 33, no. 4 (August 15, 2001): 582–83. https://doi.org/10.1086/321906.
Frothingham R. Mortality rates in comparative trials of formulations of amphotericin B. Clin Infect Dis. 2001 Aug 15;33(4):582–3.
Frothingham, R. “Mortality rates in comparative trials of formulations of amphotericin B.” Clin Infect Dis, vol. 33, no. 4, Aug. 2001, pp. 582–83. Pubmed, doi:10.1086/321906.
Frothingham R. Mortality rates in comparative trials of formulations of amphotericin B. Clin Infect Dis. 2001 Aug 15;33(4):582–583.

Published In

Clin Infect Dis

DOI

10.1086/321906

ISSN

1058-4838

Publication Date

August 15, 2001

Volume

33

Issue

4

Start / End Page

582 / 583

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Randomized Controlled Trials as Topic
  • Phosphatidylglycerols
  • Phosphatidylcholines
  • Neutropenia
  • Mycoses
  • Microbiology
  • Liposomes
  • Humans
  • Fever